Related Experiment Videos
Clinical aspects of hypertensive myocardial fibrosis
1Division of Cardiovascular Pathophysiology, School of Medicine, University of Navarra, Pamplona, Spain. jadimar@unav.es
Insights
Hypertensive heart disease involves myocardial fibrosis, characterized by collagen buildup in the heart. Monitoring fibrosis and developing regression strategies are crucial for patient outcomes.
Area of Science:
- Cardiology
- Pathology
Background:
- Myocardial fibrosis, an accumulation of fibrillar collagens (Type I and III), is a key component of cardiac remodeling in hypertensive patients.
- This fibrosis occurs in both interstitial and perivascular spaces of the myocardium, particularly in cases of arterial hypertension with left ventricular hypertrophy.
Purpose of the Study:
- To highlight the significance of myocardial fibrosis in hypertensive heart disease.
- To emphasize the adverse effects of fibrosis on cardiac function, coronary reserve, and electrical activity.
- To underscore the clinical relevance of developing noninvasive monitoring tools and regression therapies for myocardial fibrosis.
Main Methods:
- Histologic examination of myocardial tissue.
- Analysis of collagen type I and type III accumulation.
- Correlation of fibrosis with cardiac function, coronary reserve, and electrical activity.
Main Results:
- Exaggerated interstitial and perivascular accumulation of fibrillar collagens type I and III was observed in hypertensive patients.
- Hypertensive myocardial fibrosis was linked to abnormalities in cardiac function, coronary reserve, and electrical activity.
- These abnormalities adversely affect the clinical outcome of patients with hypertensive heart disease.
Conclusions:
- Myocardial fibrosis is a critical factor in hypertensive heart disease.
- Noninvasive monitoring tools for fibrosis are needed.
- Pharmacological strategies to promote fibrosis regression are clinically relevant for improving patient outcomes.
Abstract:
Myocardial fibrosis is one of the histologic constituents of myocardial remodeling present in hypertensive patients with hypertensive heart disease. In fact, an exaggerated interstitial and perivascular accumulation of fibrillar collagens type I and type III has been found in the myocardium of patients with arterial hypertension and left ventricular hypertrophy. Hypertensive myocardial fibrosis has been shown to facilitate abnormalities of cardiac function, coronary reserve, and electrical activity that adversely affect the clinical outcome of hypertensive patients. Therefore, development of noninvasive tools for the monitoring of myocardial fibrosis and pharmacological strategies aimed to promote the regression of fibrosis could be of particular relevance in the clinical treatment of patients with hypertensive heart disease.